A detailed history of Panagora Asset Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Panagora Asset Management Inc holds 748,252 shares of ABBV stock, worth $127 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares
748,252
Previous 440,136 70.0%
Holding current value
$127 Million
Previous $75.5 Million 95.73%
% of portfolio
0.72%
Previous 0.38%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$163.84 - $199.33 $50.5 Million - $61.4 Million
308,116 Added 70.0%
748,252 $148 Million
Q2 2024

Jul 29, 2024

SELL
$154.79 - $180.76 $59.9 Million - $69.9 Million
-386,883 Reduced 46.78%
440,136 $75.5 Million
Q1 2024

May 07, 2024

SELL
$159.82 - $182.1 $611,631 - $696,896
-3,827 Reduced 0.46%
827,019 $151 Million
Q4 2023

Feb 08, 2024

BUY
$137.6 - $154.97 $23.6 Million - $26.5 Million
171,314 Added 25.98%
830,846 $129 Million
Q3 2023

Oct 31, 2023

SELL
$133.59 - $154.65 $2.79 Million - $3.23 Million
-20,869 Reduced 3.07%
659,532 $98.3 Million
Q2 2023

Aug 11, 2023

SELL
$132.51 - $164.9 $5.97 Million - $7.43 Million
-45,043 Reduced 6.21%
680,401 $91.7 Million
Q1 2023

May 11, 2023

BUY
$144.61 - $166.54 $5.46 Million - $6.29 Million
37,754 Added 5.49%
725,444 $116 Million
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $5.59 Million - $6.7 Million
40,421 Added 6.24%
687,690 $111 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $4.08 Million - $4.68 Million
30,381 Added 4.92%
647,269 $86.9 Million
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $13.7 Million - $17.5 Million
99,775 Added 19.29%
616,888 $94.5 Million
Q1 2022

May 12, 2022

SELL
$131.98 - $163.75 $34.2 Million - $42.5 Million
-259,272 Reduced 33.39%
517,113 $83.8 Million
Q4 2021

Feb 10, 2022

BUY
$107.43 - $135.93 $2.25 Million - $2.84 Million
20,910 Added 2.77%
776,385 $105 Million
Q3 2021

Nov 10, 2021

BUY
$106.4 - $120.78 $9.1 Million - $10.3 Million
85,530 Added 12.77%
755,475 $81.5 Million
Q2 2021

Aug 11, 2021

SELL
$105.21 - $117.21 $3.1 Million - $3.46 Million
-29,480 Reduced 4.21%
669,945 $75.5 Million
Q1 2021

May 12, 2021

BUY
$102.3 - $112.62 $66.1 Million - $72.7 Million
645,670 Added 1201.13%
699,425 $75.7 Million
Q4 2020

Feb 10, 2021

SELL
$80.49 - $108.67 $70.4 Million - $95.1 Million
-874,910 Reduced 94.21%
53,755 $5.76 Million
Q3 2020

Nov 13, 2020

SELL
$85.91 - $100.83 $17.4 Million - $20.4 Million
-202,049 Reduced 17.87%
928,665 $81.3 Million
Q2 2020

Aug 12, 2020

SELL
$73.37 - $98.18 $4.51 Million - $6.03 Million
-61,461 Reduced 5.16%
1,130,714 $111 Million
Q1 2020

May 14, 2020

SELL
$64.5 - $97.79 $4.37 Million - $6.62 Million
-67,728 Reduced 5.38%
1,192,175 $90.8 Million
Q4 2019

Feb 12, 2020

SELL
$72.13 - $90.25 $2.04 Million - $2.56 Million
-28,313 Reduced 2.2%
1,259,903 $112 Million
Q3 2019

Nov 12, 2019

SELL
$62.98 - $75.72 $18.9 Million - $22.8 Million
-300,568 Reduced 18.92%
1,288,216 $97.5 Million
Q2 2019

Aug 09, 2019

BUY
$65.7 - $83.98 $87.9 Million - $112 Million
1,337,547 Added 532.38%
1,588,784 $116 Million
Q1 2019

May 15, 2019

SELL
$77.14 - $90.79 $5.71 Million - $6.72 Million
-74,047 Reduced 22.76%
251,237 $20.2 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $1.62 Million - $2 Million
-20,832 Reduced 6.02%
325,284 $30 Million
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $54.7 Million - $60.8 Million
-615,307 Reduced 64.0%
346,116 $32.7 Million
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $34 Million - $40.2 Million
-378,710 Reduced 28.26%
961,423 $89.1 Million
Q1 2018

May 15, 2018

BUY
$92.01 - $123.21 $62.4 Million - $83.6 Million
678,653 Added 102.6%
1,340,133 $127 Million
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $7.97 Million - $8.74 Million
-89,043 Reduced 11.86%
661,480 $64 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $52.4 Million - $67 Million
750,523
750,523 $66.7 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $300B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.